ABIOMED, Inc.

NASDAQ: ABMD
$281.42
+$2.92 (+1.0%)
Closing price October 23, 2020
Monday was a down day for the broad U.S. markets with the Nasdaq especially taking it on the chin. Crude oil pulled back in the session as well. The S&P 500 sectors were more or less split down...
While the health care sector as a whole has had its ups and downs, there is no question that mergers and acquisitions can spike interest in the companies fast. Many on Wall Street feel that is...
The top analyst upgrades, downgrades and other research calls from Thursday include Bed Bath & Beyond, BlackBerry, ConocoPhillips, JPMorgan, Micron Technology, PGE and Wells Fargo.
The top analyst upgrades, downgrades and other research calls from Monday include Adobe, Apple, Bristol-Myers, Citigroup, Ford, Groupon, Phillips 66 and United Rentals.
The top analyst upgrades, downgrades and other research calls from Friday include GoPro, KB Home, Rite Aid, Visa and Wynn Resorts.
The top analyst upgrades, downgrades and other research calls from Monday include BlackBerry, BP, Camping World, Deere, GrubHub, KLA-Tencor, Teva Pharmaceutical and Zions Bancorp.
The top analyst upgrades, downgrades and initiations seen on Thursday include AMD, Panera, SeaWorld, T-Mobile, Walgreens and 8Point3.
A new research report from Jefferies notes that when price momentum has been as bad as it has been recently, it tends to rebound in a big way.
Jefferies searches for growth with reasonable valuations and upside potential. This week's picks are no exception to that rule.
24/7 Wall St. has highlighted a few companies that missed their earnings, contrary to the trend, when they reported this past week.
Abiomed reported better-than-expected fiscal second-quarter financial results before the markets opened on Thursday.
In a new report, Jefferies is out with three very good new growth stock ideas for investors. Two of the picks are aggressive biotech and medical device plays, and one a leading retailer.
The jump in market volatility did not deter executives and 10% shareholders this week, and insider buying stayed solid.
Source: Jon OggThese are some of the top analyst upgrades, downgrades and initiations seen in Wall Street research calls this Tuesday.ABIOMED Inc. (NASDAQ: ABMD) Cut to Neutral at Lazard...
These are some of the top pre-market analyst upgrades and positive calls which we have seen early this Wednesday morning: Abiomed (ABMD) Raised to Buy at UBS. ASML (ASML) Raised to Buy at ING. CB...